guidesApril 25, 2026·6 min read

Klow Dosage & Frequency Chart: 80mg Protocol

4 peptides in one vial — but the math changes everything. Reconstitution, per-injection dosing, and why KPV makes this more than Glow.

Klow Blend Dosing Guide

The Klow blend combines GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg) in a single 80mg vial. Four peptides, one reconstitution, one injection per session. KPV's direct NF-kB suppression is what separates Klow from the Glow blend.

Research-context information only. The KLOW blend is a research-peptide blend containing KPV, BPC-157, GHK-Cu, and TB-500. Protocols, doses, and reactions reported below come from published research and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.

Summer Savings

Save up to 50% on KLOW this summer

Active discount codes at our recommended KLOW vendors — apply at checkout. Every source is COA-tested.

Ascension Peptides50% offTHEPEPTIDECATALOGNura Peptide25% offthepeptidecatalogGlacier Aminos10% offthepeptidecatalogEZ Peptides10% offthepeptidecatalog
See KLOW deals

Codes shown are ongoing offers with no set end date. Links are affiliate links — we may earn a commission.

KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) Dosing Table

Match your vial size below — reconstitution and dose math update automatically.

Reconstitute: add 2 mL of bacteriostatic water to the 80 mg vial. Resulting concentration: 40 mg/mL.

Vials are labeled "50/10/10/10" — 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 + 10 mg KPV (80 mg total).

2 mg blend5 units · 0.05 mL
Daily SubQ
Standard
4 mg blend10 units · 0.1 mL
Daily SubQ
Loading

Math assumes U-100 insulin syringes (1 mL = 100 units). Verify your syringe matches before injecting. Round half-units to the nearest visible mark.

Klow Dosage & Frequency Chart

Parameter Community Protocol
Loading dose 10 units on insulin syringe (4 mg total blend), 5x/week — weeks 1-4
Maintenance dose 5 units (2 mg total blend), 3x/week — weeks 5-12
Route Subcutaneous injection
Timing AM
Cycle 8-12 weeks on, 4-8 weeks off
Vial size 80 mg
Reconstitution 2 mL bacteriostatic water → 40 mg/mL
Storage Refrigerate, use within 28 days

The dose steps down between phases: 10 units during loading, then 5 units for maintenance — the frequency drops from 5x to 3x weekly at the same time.

Per injection: at 10 units (loading) — GHK-Cu 2.50 mg, KPV 500 mcg, BPC-157 500 mcg, TB-500 500 mcg. At 5 units (maintenance), each component is exactly half that. All within standard dosing ranges.

Peptide Amount in Vial Per 5 Units Per 10 Units
GHK-Cu 50 mg (62.5%) 1.25 mg 2.50 mg
KPV 10 mg (12.5%) 250 mcg 500 mcg
BPC-157 10 mg (12.5%) 250 mcg 500 mcg
TB-500 10 mg (12.5%) 250 mcg 500 mcg

Cycling Details

Loading (Weeks 1-4): 10 units 5x/week (weekdays on, weekends off). One vial lasts 4 weeks at 50 units/week. Weekly totals: GHK-Cu 12.5 mg, KPV 2.5 mg, BPC-157 2.5 mg, TB-500 2.5 mg.

Maintenance (Weeks 5-12): 5 units 3x/week (half the loading dose). At 15 units/week, one vial covers ~13 weeks of maintenance. A full 12-week cycle (4 weeks loading + 8 weeks maintenance) runs ~2 vials.

Injury Recovery Cycle (aggressive): Daily injections (7x/week, 10 units) for weeks 1-2, then standard loading for weeks 3-6, then maintenance for weeks 7-10.

Reconstitution Quick Reference

Vial Size BAC Water Concentration 10-Unit Dose
80 mg 2 mL 40 mg/mL 4 mg total blend

80 mg vial + 2 mL BAC water = 40 mg/mL. A standard 10-unit dose delivers 4 mg total blend.

Community protocols describe gentle swirling — not shaking — to avoid degradation, with storage at 2–8°C and use within 28 days. For the full step-by-step walkthrough, see the Klow Reconstitution Guide.

Top Klow Blend Vendors

Ranked by price, COA availability, and reputation

Affiliate disclosure: vendor links in this article are affiliate links — The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you.

Where These Numbers Come From

The Klow blend combines four peptides with established individual dosing protocols into fixed ratios that deliver standard doses per injection.

GHK-Cu (Pickart & Margolina, 2018): Activates 4,000+ genes for tissue remodeling, collagen synthesis, and stem cell recruitment. The 2.5 mg per injection is within standard research ranges.

KPV (Dalmasso et al., 2008): Alpha-MSH fragment that directly suppresses NF-kB — the master inflammatory switch. Transported via PepT1 into intestinal cells, providing gut-specific anti-inflammatory effects alongside systemic NF-kB inhibition (Brzoska et al., 2007).

BPC-157 (Sikiric et al., 2014): Angiogenesis driver through VEGF and nitric oxide modulation. 500 mcg per injection matches standalone protocols.

TB-500 (Malinda et al., 1999): Cell migration via LKKTET actin-binding domain. 500 mcg per injection aligns with standard daily dosing.

The four peptides cover distinct phases of healing: inflammation control (KPV), vascularization (BPC-157), cell recruitment (TB-500), and tissue remodeling (GHK-Cu).

Klow vs Glow vs Wolverine Stack

Feature Klow (80mg) Glow (70mg) Wolverine Stack (20mg)
BPC-157 10 mg 10 mg 10 mg
TB-500 10 mg 10 mg 10 mg
GHK-Cu 50 mg 50 mg --
KPV 10 mg -- --
NF-kB targeting Direct (KPV) Indirect None
Best for Repair + inflammation + gut Repair + collagen Pure injury recovery

Klow is commonly chosen by: users whose protocols target systemic inflammation, gut issues, autoimmune-related tissue damage, or post-surgical recovery — community sources describe KPV's NF-kB mechanism as the differentiator in these contexts. Glow is commonly chosen by: users focused on musculoskeletal repair or collagen support without a significant inflammatory component. Wolverine is commonly chosen by: users whose protocols center on acute injury recovery without a collagen or anti-aging layer.

Side Effects & Safety

Community-reported side effects for this blend combination include:

  • Injection site redness — community sources typically describe mild redness resolving within 30-60 minutes
  • Slight drowsiness — self-reported in the first week, attributed by community sources to GHK-Cu
  • Mild warmth or flushing — reported by users, attributed to KPV's alpha-MSH fragment activity; described as transient
  • Nausea — community sources most commonly report this in the first 2-3 injections, described as dose-dependent
  • Headache — occasionally self-reported; community discussion attributes this to BPC-157's nitric oxide modulation
  • All four peptides are research compounds without FDA approval
  • No human clinical trials for this specific combination

Ready to buy? Compare verified vendors on our best Klow Blend sources page, or browse all coupon codes for up to 50% off.

mg to Units Conversion

On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL). Because this is a pre-mixed blend, a single draw delivers all components together in fixed ratio. The KLOW blend is dosed by total milligrams drawn; the four components stay in their fixed manufacturing ratio.

Reconstitution A: 80 mg vial + 2 mL BAC water (40 mg/mL total) — the standard dilution from the Quick Reference above.

Total blend dose Volume (mL) Units (insulin syringe)
2 mg 0.05 mL 5 units
4 mg 0.1 mL 10 units
6 mg 0.15 mL 15 units
8 mg 0.2 mL 20 units

Reconstitution B: 80 mg vial + 3 mL BAC water (26.7 mg/mL total) — more BAC water for larger, easier-to-measure draws.

Total blend dose Volume (mL) Units (insulin syringe)
2 mg 0.075 mL 7.5 units
4 mg 0.15 mL 15 units
6 mg 0.225 mL 22.5 units
8 mg 0.3 mL 30 units

These conversions reflect the dilutions documented in community reconstitution protocols. They report how the math is described, not a recommended dosing schedule.

Frequently Asked Questions

What is the Klow blend?
Klow is a pre-mixed 4-peptide blend containing GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg) — 80mg total per vial. It combines tissue repair, anti-aging, and anti-inflammatory peptides into a single injection.
What is the standard Klow injection dose?
The community protocol steps down by phase: 10 units on an insulin syringe (4 mg total blend: 2.5 mg GHK-Cu, 500 mcg KPV, 500 mcg BPC-157, 500 mcg TB-500) 5x/week during loading, then 5 units (2 mg total blend) 3x/week for maintenance. Cycle 8-12 weeks on, 4-8 weeks off.
What reconstitution protocol do community sources describe for Klow?
Community reconstitution protocols describe adding 2 mL of bacteriostatic water to the 80mg vial, yielding 40 mg/mL. Swirling gently (not shaking) is the standard method. Refrigeration at 2-8°C and use within 28 days is the documented storage protocol.
What is the difference between Klow and Glow?
Glow contains BPC-157, TB-500, and GHK-Cu (70mg total). Klow adds KPV (10mg) for NF-kB-mediated anti-inflammatory action, making it better suited for protocols targeting systemic inflammation or gut issues alongside tissue repair.
How do community users compare buying the Klow blend versus individual peptides?
Community sources describe blends as more convenient (one vial, one injection) and often lower cost per cycle. Individual peptides allow dose-ratio adjustment; community sources note this is the common preference when running fewer than all four components.
How long should a Klow cycle last?
Most protocols run 8-12 weeks, followed by 4-8 weeks off. Loading phase at 5x/week for 4 weeks, then 3x/week maintenance for the remaining weeks.
30ml bacteriostatic water vial — 0.9% benzyl alcohol multi-dose
Bac Water Made for Peptides
Don't risk a $300 peptide on generic bac water.
Most cloudy reconstitutions trace back to one thing — and it isn't the peptide. Sterile, non-pyrogenic, 0.9% benzyl alcohol — formulated for peptide reconstitution, not repackaged from generic stock.
0.9% benzyl alcohol Made for peptides 30 mL multi-dose
See why our bac water doesn't ruin peptides
30ml from $18.75 · Ships fast · Code thepeptidecatalog

References

Citation Topic PMID
Pickart & Margolina, Int J Mol Sci (2018) GHK-Cu gene expression, 4,000+ genes 29986520
Pickart, J Biomedicine & Biotechnology (2008) GHK-Cu collagen synthesis, copper pathways 19133135
Dalmasso et al., Gastroenterology (2008) PepT1-mediated KPV uptake, NF-kB inhibition 18061177
Brzoska et al., Ann NY Acad Sci (2007) Alpha-MSH peptides as anti-inflammatory drugs 17934097
Catania et al., FASEB J (2000) KPV antimicrobial effects 10670585
Sikiric et al., Curr Pharm Des (2014) BPC-157 nitric oxide system 23755725
Malinda et al., PNAS (1999) TB-500 LKKTET actin-binding mechanism 10469335
Bock-Marquette et al., Nature (2004) Thymosin Beta-4 cardiac protection 15565145

For educational and research purposes only. This is not medical advice. The Klow blend contains research peptides with no FDA approval.